Efficacy and safety of botensilimab (BOT) plus balstilimab (BAL) in patients (pts) with refractory metastatic sarcoma-MedSci.cn

Efficacy and safety of botensilimab (BOT) plus balstilimab (BAL) in patients (pts) with refractory metastatic sarcoma

Wilky, B; Trent, JC; Gordon, M; El-Khoueiry, AB; Bullock, A; Henick, BS; Schwartz, GK; Agulnik, M; Mahadevan, D; Patel, J; Grossman, J; Rosenthal, K; O'Day, SJ; Tsimberidou, AM

ANNALS OF ONCOLOGY, 2023; 34 (): S1032

科室
- - 订阅+
  - 更多科室
工具
服务